Expect to be asked why youre leaving
Rare, but serious
This decline isn't just about feeling a bit more tired
Central to this is the ability of the copper ion to transition between the oxidation states Cu(II) and Cu(I)
Additionally, a significant trial demonstrated an average weight loss of 12.4% from baseline weight over 68 weeks FDA approval: Wegovy received FDA approval on June 4, 2021, for long-term weight management in adults with obesity or those being overweight, marking it as a recent advancement in weight loss treatments The safety profile of Wegovy includes several important considerations: Potential risks: Users should be aware of serious side effects like thyroid tumors, pancreatitis, gallbladder problems, and increased heart rate, among others Drug interactions: Its crucial to inform healthcare providers of all medications taken, as Wegovy can interact with other drugs, especially those used for diabetes management
Methods Network characteristics We performed a retrospective cohort study of all patients aged 18 or over with type 1 diabetes using the TriNetX platform
